Strumento inattivo

Altre lingue HTG Molecular Diagnostics Inc Nasdaq

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
-	-

2023	Nominato un fiduciario/esaminatore ai sensi del Capitolo 11 per HTG Molecular Diagnostics, Inc.	CI
2023	Htg Molecular Diagnostics, Inc. annuncia la cessazione del rapporto di lavoro di Byron T. Lawson in qualità di Vice Presidente Senior e Direttore Commerciale	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc.	25/08/23
Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc.	16/08/23
Trustee/Examiner Appointed Under Chapter 11 for HTG Molecular Diagnostics, Inc.	21/07/23
HTG Molecular Diagnostics, Inc.(OTCPK:HTGM.Q) dropped from NASDAQ Composite Index	14/06/23
HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	08/06/23
HTG Molecular Diagnostics, Inc.(NasdaqCM:HTGM) dropped from S&P TMI Index	08/06/23
Htg Molecular Diagnostics, Inc. Announces Termination of Employment of Byron T. Lawson as Senior Vice President and Chief Commercial Officer	05/06/23
HTG Molecular Diagnostics, Inc. Filed for Bankruptcy	05/06/23
HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention	18/05/23
HTG Molecular Diagnostics, Inc. to Highlight the Advantages of its Drug Discovery Engine at the 2023 Biotechnology Innovation Organization	18/05/23
Top Premarket Gainers	17/05/23
HTG Highlights the Advantages of Its Drug Discovery Engine	16/05/23
HTG Molecular Diagnostics : Reports First Quarter 2023 Results and Provides Recent Business Highlights - Form 8-K	11/05/23
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights	10/05/23
HTG MOLECULAR DIAGNOSTICS, INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10/05/23
HTG Molecular Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05/23
HTG MOLECULAR DIAGNOSTICS, INC : Other Events (form 8-K)	25/04/23
HTG Provides Update on Drug Discovery Partnering Initiative	25/04/23
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery	18/04/23
HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19	06/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue HTG Molecular Diagnostics Inc Nasdaq

Azioni

Altre lingue

Filtri